Home/Recalls/CANADA-55921
Health CanadaGeneral Alert

ADEMPAS (riociguat) - New Contraindication for Patients with Pulmonary Hypertens...

Published: August 15, 2016Recall ID: 55921Category: generalCountry: Canada

Reason for Recall / Hazard

Product safety

Product Description & Identification

ADEMPAS (riociguat) - New Contraindication for Patients with Pulmonary Hypertension Associated with Idiopathic Interstitial Pneumonias (PH-IIP)

Additional Source Details

FieldValue
N I D55921
U R Lhttps://recalls-rappels.canada.ca/en/alert-recall/adempas-riociguat-new-contraindication-patients-pulmonary-hypertension-associated
IssueProduct safety
Title ADEMPAS (riociguat) - New Contraindication for Patients with Pulmonary Hypertension Associated with Idiopathic Interstitial Pneumonias (PH-IIP)
Archived1
CategoryDrugs
Last updated2016-08-15
OrganizationMarketed health products

Overview

  • Recalling FirmMarketed health products
Official Agency Alert